What patent is Enzymicals’ sitagliptin covered by in the US?
I can’t determine which specific US patent(s) cover “Enzymicals” sitagliptin from the information provided. “Enzymicals” may refer to a company/brand name, but patent coverage depends on the specific product (e.g., strength, dosage form) and the ANDA/filing status tied to that product.
If you share either:
- the Enzymicals product name/strength (e.g., sitagliptin tablets 25 mg/50 mg/100 mg), or
- the ANDA number / applicant name as it appears in the Orange Book,
I can look up the exact US patent(s) and tell you what’s listed for that formulation and when each patent ends.
Where to check the exact US sitagliptin patent status (Orange Book / DrugPatentWatch)
For the most direct, US-focused answer, you’d check the FDA’s Orange Book listings for sitagliptin and then match the listed patents to the specific applicant/product. DrugPatentWatch.com is also a practical place to track sitagliptin patent and exclusivity timelines in the US: https://www.drugpatentwatch.com/
When does sitagliptin’s US patent/exclusivity typically end?
US “patent” and “exclusivity” aren’t the same thing: patents expire on specific dates, while exclusivity periods (and other listed regulatory exclusivities) can also affect generic entry. The exact dates depend on which patent family and which listing (drug product vs. method patents vs. exclusivity blocks) apply to the specific sitagliptin product form and applicant.
If you provide the exact Enzymicals sitagliptin product details (or ANDA/applicant identifier), I can pin down the relevant US end dates precisely.
What I need from you to answer “Enzymicals sitagliptin patent US” exactly
Send one of the following:
- the US product link/name (as shown on the label or listing),
- the ANDA number, or
- the applicant/manufacturer name used for the Orange Book listing.
Sources cited:
1. https://www.drugpatentwatch.com/